China Feihe IPO Preview: The Winning Formula?
China Feihe (FEIHE HK) is the leading player in the China IMF (infant milk formula) market as measured by retail sales value in 2018, according to...
796 Views
The Market's Souring on A2 Milk Offers a Sweet Deal for Investors
Looking past the near-term risks to reap the high growth opportunities of the Chinese infant formula market.Concerns over increasing infant formula...
483 Views
A2 Milk the Cream of the Crop; Initiating With Narrow Moat and NZD 14.60 (AUD 13.30) FVE
The A2 Milk Co Ltd (A2M AU) is set to enjoy high growth and stellar returns on invested capital, supporting our NZD 14.60 (AUD 13.30) per share...
528 Views
A2M:ASX A Simple Metric to Support a High-Conviction Investment Decision
Edgware has said since December last year that A2M:ASX was a new type of blue chip company with organic earnings power that will see its earnings...
912 Views
A2M Guidance Confirms Infant Formula Regulatory Clouds Clearing in China
The modest A2M FY16 upgrade this morning to revenue of NZ$350-360m and operating EBITDA of NZ$52-54m remains light on new operating detail. While...
242 Views